University of Southampton
Bjorn Frendeus is an accomplished scientist with extensive experience in therapeutic antibody discovery and development. Since February 2003, Frendeus has held multiple leadership positions at BioInvent International AB, including Chief Scientific Officer and Acting CEO. Responsibilities have included overseeing preclinical research in cardiometabolism, inflammation, immunology, and oncology. In addition, Frendeus is a Visiting Professor at the University of Southampton and has contributed as a reviewer and speaker in various scientific forums, including The Journal of Clinical Investigation and Cambridge Healthtech Institute. Frendeus possesses a Ph.D. in Immunology and Microbiology and a Master of Science in Molecular Biology from Lund University.
This person is not in any teams
This person is not in any offices